Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors

NCT04675320 is registered in ClinicalTrials.gov with Centre Georges Francois Leclerc as lead sponsor.

NCT NCT04675320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04675320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors
Lead sponsor
Centre Georges Francois Leclerc
Phase
Observational
Overall status
Unknown status
Start date
July 7, 2020
Completion date
November 10, 2024
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer